ORGO — Organogenesis Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapContrarian

Annual balance sheet for Organogenesis Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	114	102	104	136	93.7
Net Total Accounts Receivable
Net Total Receivables	82.5	89.5	82	110	217
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	227	223	225	286	362
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	128	146	156	126	159
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	443	449	460	498	599
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	82	75	80.5	77.5	100
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	201	184	181	113	165
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	242	266	279	385	434
Total Liabilities & Shareholders' Equity	443	449	460	498	599
Total Common Shares Outstanding
Total Preferred Shares Outstanding